Literature DB >> 19268665

Microglia enhance manganese chloride-induced dopaminergic neurodegeneration: role of free radical generation.

Ping Zhang1, Tamika A Wong, Kyle M Lokuta, Deanne E Turner, Kristina Vujisic, Bin Liu.   

Abstract

Exposure to elevated levels of manganese has been shown to cause neuronal damage in the midbrain and the development of Parkinsonian symptoms. Activation of microglia and release of neurotoxic factors in particular free radicals are known to contribute to neurodegeneration. We have recently reported that manganese chloride (MnCl(2)) stimulates microglia to produce reactive oxygen species (ROS). The aim of this study is to determine the role of microglia in the MnCl(2)-induced degeneration of dopaminergic (DA) neurons that are particularly vulnerable to oxidative insult. MnCl(2) (10-300 microM; 7 days) was markedly more effective in damaging DA neurons in the rat mesencephalic neuron-glia cultures than the neuron-enriched (microglia-depleted) cultures. In addition, the microglia-enhanced MnCl(2) toxicity was found to be preferential to DA neurons. The microglial enhancement of DA neurotoxicity was further supported by the observation that replenishment of microglia to the neuron-enriched cultures significantly increased the susceptibility of DA neurons to the MnCl(2)-induced damage. Analysis of the temporal relationship between microglial activation and DA neurodegeneration revealed that MnCl(2)-stimulated microglial activation preceded DA neurodegeneration. Mechanistically, MnCl(2) (10-300 microM) stimulated a concentration- and time-dependent robust production of ROS and moderate production of nitric oxide but no detectable release of tumor necrosis factor-alpha and interleukin-1beta. Application of free radical scavengers including superoxide dismutase/catalase, glutathione, N-acetyl cysteine and an inhibitor of nitric oxide biosynthesis significantly protected DA neurons against the MnCl(2)-induced degeneration. These results demonstrate that microglial activation and the production of reactive nitrogen and oxygen free radicals promote the MnCl(2)-induced DA neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19268665      PMCID: PMC2673144          DOI: 10.1016/j.expneurol.2009.02.013

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  68 in total

1.  Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia.

Authors:  W G Kim; R P Mohney; B Wilson; G H Jeohn; B Liu; J S Hong
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Manganese potentiates nuclear factor-kappaB-dependent expression of nitric oxide synthase 2 in astrocytes by activating soluble guanylate cyclase and extracellular responsive kinase signaling pathways.

Authors:  Julie A Moreno; Kelly A Sullivan; David L Carbone; William H Hanneman; Ronald B Tjalkens
Journal:  J Neurosci Res       Date:  2008-07       Impact factor: 4.164

3.  Microglial expression of the prion protein.

Authors:  D R Brown; A Besinger; J W Herms; H A Kretzschmar
Journal:  Neuroreport       Date:  1998-05-11       Impact factor: 1.837

Review 4.  Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease.

Authors:  Bin Liu
Journal:  AAPS J       Date:  2006-09-29       Impact factor: 4.009

5.  GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures.

Authors:  S C Lee; W Liu; C F Brosnan; D W Dickson
Journal:  Glia       Date:  1994-12       Impact factor: 7.452

6.  Protein kinase Cdelta is a key downstream mediator of manganese-induced apoptosis in dopaminergic neuronal cells.

Authors:  Calivarathan Latchoumycandane; Vellareddy Anantharam; Masashi Kitazawa; Yongjie Yang; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  J Pharmacol Exp Ther       Date:  2004-12-17       Impact factor: 4.030

7.  Manganese-induced reactive oxygen species: comparison between Mn+2 and Mn+3.

Authors:  S F Ali; H M Duhart; G D Newport; G W Lipe; W Slikker
Journal:  Neurodegeneration       Date:  1995-09

8.  Manganese potentiates lipopolysaccharide-induced expression of NOS2 in C6 glioma cells through mitochondrial-dependent activation of nuclear factor kappaB.

Authors:  Rola Barhoumi; Jennifer Faske; Xuhong Liu; Ronald B Tjalkens
Journal:  Brain Res Mol Brain Res       Date:  2004-03-30

9.  Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese.

Authors:  E-K Tan; C Tan; S M C Fook-Chong; S Y Lum; A Chai; H Chung; H Shen; Y Zhao; M L Teoh; Y Yih; R Pavanni; V R Chandran; M C Wong
Journal:  J Neurol Sci       Date:  2003-12-15       Impact factor: 3.181

Review 10.  Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease.

Authors:  Manfred Gerlach; Kay L Double; Dorit Ben-Shachar; Luigi Zecca; Moussa B H Youdim; Peter Riederer
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978

View more
  21 in total

1.  Manganese potentiates LPS-induced heme-oxygenase 1 in microglia but not dopaminergic cells: role in controlling microglial hydrogen peroxide and inflammatory cytokine output.

Authors:  Celia A Dodd; Nikolay M Filipov
Journal:  Neurotoxicology       Date:  2011-09-25       Impact factor: 4.294

2.  Manganese modulation of MAPK pathways: effects on upstream mitogen activated protein kinase kinases and mitogen activated kinase phosphatase-1 in microglial cells.

Authors:  Patrick L Crittenden; Nikolay M Filipov
Journal:  J Appl Toxicol       Date:  2011-01       Impact factor: 3.446

3.  Protective effects of antioxidants and anti-inflammatory agents against manganese-induced oxidative damage and neuronal injury.

Authors:  Dejan Milatovic; Ramesh C Gupta; Yingchun Yu; Snjezana Zaja-Milatovic; Michael Aschner
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-13       Impact factor: 4.219

Review 4.  Environmental neurotoxicant-induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms.

Authors:  Arthi Kanthasamy; Huajun Jin; Adhithiya Charli; Anantharam Vellareddy; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

Review 5.  α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease.

Authors:  Jason P Covy; Benoit I Giasson
Journal:  Neurotoxicology       Date:  2011-01-14       Impact factor: 4.294

6.  Minocycline Rescues from Zinc-Induced Nigrostriatal Dopaminergic Neurodegeneration: Biochemical and Molecular Interventions.

Authors:  Vinod Kumar; Brajesh Kumar Singh; Amit Kumar Chauhan; Deepali Singh; Devendra Kumar Patel; Chetna Singh
Journal:  Mol Neurobiol       Date:  2015-03-13       Impact factor: 5.590

7.  Oxidative damage and neurodegeneration in manganese-induced neurotoxicity.

Authors:  Dejan Milatovic; Snjezana Zaja-Milatovic; Ramesh C Gupta; Yingchun Yu; Michael Aschner
Journal:  Toxicol Appl Pharmacol       Date:  2009-07-14       Impact factor: 4.219

Review 8.  Air pollution: mechanisms of neuroinflammation and CNS disease.

Authors:  Michelle L Block; Lilian Calderón-Garcidueñas
Journal:  Trends Neurosci       Date:  2009-08-26       Impact factor: 13.837

9.  Synergistic dopaminergic neurotoxicity of manganese and lipopolysaccharide: differential involvement of microglia and astroglia.

Authors:  Ping Zhang; Kyle M Lokuta; Deanne E Turner; Bin Liu
Journal:  J Neurochem       Date:  2009-11-06       Impact factor: 5.372

10.  Characterization of a SILAC method for proteomic analysis of primary rat microglia.

Authors:  Ping Zhang; Ashley E Culver-Cochran; Stanley M Stevens; Bin Liu
Journal:  Proteomics       Date:  2016-04-13       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.